<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API)</title>
    <link>https://www.taxtmi.com/notifications?id=137422</link>
    <description>Export restrictions have been imposed with immediate effect on Enoxaparin and Intra Venous Immunoglobulin (IVIG), including formulations and APIs, by reclassifying specified ITC (HS) entries from free to restricted in Schedule 2 of the ITC(HS) Export Policy 2018, thereby subjecting such exports to regulatory controls and any applicable licensing requirements under the Foreign Trade Policy.</description>
    <language>en-us</language>
    <pubDate>Mon, 10 Jan 2022 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 11 Jan 2022 09:31:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=666703" rel="self" type="application/rss+xml"/>
    <item>
      <title>Amendment in Export Policy of Enoxaparin (formulation and API) and Intra-Venous Immunoglobulin (IVIG) (formulation and API)</title>
      <link>https://www.taxtmi.com/notifications?id=137422</link>
      <description>Export restrictions have been imposed with immediate effect on Enoxaparin and Intra Venous Immunoglobulin (IVIG), including formulations and APIs, by reclassifying specified ITC (HS) entries from free to restricted in Schedule 2 of the ITC(HS) Export Policy 2018, thereby subjecting such exports to regulatory controls and any applicable licensing requirements under the Foreign Trade Policy.</description>
      <category>Notifications</category>
      <law>DGFT</law>
      <pubDate>Mon, 10 Jan 2022 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/notifications?id=137422</guid>
    </item>
  </channel>
</rss>